Clinical Efficacy of L-Ornithine–L-Aspartate in the Management of Hepatic Encephalopathy

Abstract

The clinical efficacy of both oral and parenteral L-ornithine–L-aspartate (OA) was confirmed by randomized, placebo-controlled, double-blind studies in patients with manifest hepatic encephalopathy and hyperammonemia. The drug was able to reduce high blood ammonia levels induced either by ammonium chloride or protein ingestion or existing as a clinical… (More)
DOI: 10.1023/A:1021934607762

8 Figures and Tables

Topics

  • Presentations referencing similar topics